Key facts
- This page summarizes David J. Croyle's Form 4 filing for CALLAN JMB INC. (CJMB).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 26 Mar 2026, 18:19.
David J. Croyle - 20 Mar 2026 Form 4 Insider Report for CALLAN JMB INC. (CJMB)
- Reporting relationship
- Chief Medical Officer, 10%+ Owner
- Issuer ticker
- CJMB
- Reported as of
- 20 Mar 2026
- Net transaction value
- +$17,841
- SEC form
- 4
- Accepted by SEC
- 26 Mar 2026, 18:19:32 UTC
- Prior SEC filing
- 10 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ David J. Croyle
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
David J. Croyle filed Form 4 for CALLAN JMB INC. (CJMB) on 26 Mar 2026.
Change
- Previous filing in this sequence was filed on 10 Mar 2026.
- Current net transaction value: +$17,841.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002045494
Primary reporting owner
Croyle David J
- Relationship
- Chief Medical Officer, 10%+ Owner
- Address
- C/O CALLAN JMB INC., 244 FLIGHTLINE DRIVE, SPRING BRANCH
- Signature
- /s/ David J. Croyle
- Signature date
- 26 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CJMB
transaction
Common Stock
Purchase
- Transaction value
- $17,841
- Shares
- +10,195
- Change %
- +1.3%
- Price
- $1.75
- Shares after
- 800,000
- Date
- 20 Mar 2026
- Ownership
- By Rollover IRA
* marks a reported price that did not pass the local price check.